
Blood levels alone cannot confirm safe testosterone dosing. Asking about androgenic effects and allowing months for response are central to care.
The second installment in our two-part article on AIs looks at these agents as potential alternatives to clomiphene citrate and gonadotropins for stimulating fertility in breast cancer survivors.






